IntegraGen SA Announces the Publication of the Results of a Study Assessing the Impact of a Combined Analysis of Four Genetic Variants on Autism Risk

Published: May 12, 2010

EVRY, France--(BUSINESS WIRE)--IntegraGen SA, a French biotechnology company dedicated to gene discovery, announced today the publication of the results of a collaborative study reporting the use of a combined analysis of multiple genetic variants in a genetic score to help identify individuals at high risk of developing autism.

Back to news